Ramucirumab (Cyramza; Eli Lilly) is FDA-approved for 5 unique cancer indications.
Robert Mown, PharmD
Advertisement
Articles by Robert Mown, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Estradiol-Containing MHT May Impact Alzheimer Disease-Related Biomarkers in Postmenopausal Women
2
CHEST 2025: Improving Access to Chronic Cough Treatment Through a Digital Therapeutic Solution
3
CHEST 2025: Exploring the Link Between GLP-1 Receptor Agonists, Type 2 Diabetes, and Asthma Risk
4
MHT Use Can Affect Cognitive Health Depending on Administration Method
5
